Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Deprivation Therapy”

526 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 526 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01410942
What this trial is testing

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 175
Not applicableStudy completedNCT01366053
What this trial is testing

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists

Who this might be right for
Prostate Cancer
CMX Research 125
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Large-scale testing (Phase 3)Study completedNCT01215513
What this trial is testing

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 127
Not applicableStudy completedNCT01909440
What this trial is testing

Resistance Training and Protein Supplementation for Prostate Cancer Survivors

Who this might be right for
Prostate Cancer
University of Southern California 43
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Not applicableStudy completedNCT03424837
What this trial is testing

A Survivorship Care Plan and Embedded Navigation Tool

Who this might be right for
Prostate Cancer
Duke University 77
Not applicableNot Yet RecruitingNCT07724080
What this trial is testing

Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer

Who this might be right for
Prostate CancerMuscle Loss
University of Bath 40
Not applicableStudy completedNCT03776045
What this trial is testing

PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)

Who this might be right for
Prostate Cancer
University of East Anglia 50
Not applicableStudy completedNCT02869412
What this trial is testing

Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy

Who this might be right for
Prostate Carcinoma
OHSU Knight Cancer Institute 56
Not applicableStudy completedNCT06605846
What this trial is testing

Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy

Who this might be right for
Prostate
MTI University 110
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Testing effectiveness (Phase 2)Ended earlyNCT02494713
What this trial is testing

Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston 4
Not applicableStudy completedNCT01973673
What this trial is testing

Healthy Bones Study

Who this might be right for
Locally Advanced Malignant Neoplasm
University Health Network, Toronto 200
Not applicableLooking for participantsNCT06172283
What this trial is testing

Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
State University of New York at Buffalo 30
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableStudy completedNCT04341324
What this trial is testing

Effect of ADT in Chinese Male With Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 60
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Testing effectiveness (Phase 2)Study completedNCT00114985
What this trial is testing

Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 100
Next Page